Search results
Anti-Ro/SSA Antibodies Have Potential to Predict ILD in SSc
Medscape· 1 day agoAnti-Ro/SSA antibodies may help predict which patients with systemic sclerosis (SSc) are at a...
New EHA data reveal how badly Gilead's $4.9B bet on CD47 imploded
FierceBiotech· 18 hours agoGilead Sciences' abandoned anti-CD47 drug magrolimab was not just ineffective, but could potentially...
EXCLUSIVE: ImmunoPrecise Antibodies' Subsidiary Releases Software With Customizable Interface For...
Benzinga via Yahoo Finance· 5 days agoOn Monday, ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) announced that its subsidiary, BioStrand, has...
Santa Ana Bio secures $168m for inflammatory disease treatments
Pharmaceutical Technology via Yahoo Finance· 1 day agoAnother candidate, SAB03, is expected to enter Phase I trials in 2025 for several severe...
Here's Why Hold Strategy Is Apt for Danaher (DHR) Stock Now
Zacks via Yahoo Finance· 22 hours agoIn December 2023, Danaher acquired Abcam plc, a global supplier of protein consumables, for...
New Research: Convenient At-Home Test Identifies A | Newswise
Newswise· 3 days agoIn a new joint study by the George Washington University, the University of North Carolina, and others, researchers looked into the benefits of using at-home antibody tests ...
What causes long COVID? Case builds for rogue antibodies
Nature· 3 days agoStudy finds that antibodies from people with the debilitating condition trigger similar symptoms in...
What Happens to Your Body When You Take Colostrum Powder
Eating Well via Yahoo News· 21 hours agoBut, is colostrum powder worth the hype? And, most importantly, what’s really happening to your body...
New antivenom invented for black widow spider bites
Live Science via Yahoo News· 3 days agoIn the new study, the team tested more than 10 billion different antibodies in the lab to determine if any were capable of binding and neutralizing...
Adcytherix Launches with € 30m in Seed Funding to Develop Next Generation Antibody Drug Conjugates
Benzinga· 4 days agoAdcytherix Launches with € 30m in Seed Funding to Develop Next Generation Antibody Drug Conjugates Vision is to establish a leading ADC developer to treat high unmet need diseases such as cancer. Founded by the team